Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
). Besides, their microbiome was characterized by predictive functions of lipopolysaccharide biosynthesis and metabolism of glutathione, cysteine and methionine that could indirectly reflect the gut pro-inflammatory status. Urolithin detection in urine is a feasible, non-invasive and fast approach that can reflect gut microbiome dysbiosis and intestinal inflammation in Parkinson's disease patients. Our current study could provide novel strategies for improving diagnostics, and for preventing and treating disease progression in microbiota-based interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“because of dysbiosis, lipid, amino acid and energy metabolism are often dysregulated in PD patients [96,97,98,99,100]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [100]
In the citing paper
“disease severity has been associated with lower urine levels of urolithin, an anti-inflammatory molecule produced by the gut microbiota upon polyphenols intake [100]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [100]
Citations
Cites
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Current Understanding of Dysbiosis in Disease in Human and Animal Models
DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000750 · Cited by 1,122
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.008 · Cited by 823
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Larrosa, M., González-Sarrías, A., Yáñez-Gascón, M. J., Selma, M. V., Azorín-Ortuño, M., Toti, S., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.012 · Cited by 504
Self-citationDysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Tomás-Barberán, F. A., García-Villalba, R., González-Sarrías, A., Selma, M. V., & Espín, J. C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5024615 · Cited by 419
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
The role of microbial amyloid in neurodegeneration
Friedland, R. P., & Chapman, M. R. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006654 · Cited by 391
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361
Microbiota composition and metabolism are associated with gut function in Parkinson's disease
Cirstea, M. S., Yu, A. C., Golz, E., Sundvick, K., Kliger, D., Radisavljevic, N., Foulger, L. H., Mackenzie, M., Huan, T., Finlay, B. B., et al. (2020) · Movement Disorders · doi:10.1002/mds.28052 · Cited by 326
Selma, M. V., Beltrán, D., García-Villalba, R., Espín, J. C., & Tomás-Barberán, F. A. (2014) · Food Funct. · doi:10.1039/c4fo00092g · Cited by 304
Self-citationChanges of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298
Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice
Gong, Z., Huang, J., Xu, B., Ou, Z., Zhang, L., Lin, X., Ye, X., Kong, X., Long, D., Sun, X., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1450-3 · Cited by 254
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187307 · Cited by 248
González‐Sarrías, A., García‐Villalba, R., Romo‐Vaquero, M., Alasalvar, C., Örem, A., Zafrilla, P., Tomás‐Barberán, F. A., Selma, M. V., & Espín, J. C. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600830 · Cited by 230
Self-citationCharacterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia
Narushima, S., Sugiura, Y., Oshima, K., Atarashi, K., Hattori, M., Suematsu, M., & Honda, K. (2014) · Gut Microbes · doi:10.4161/gmic.28572 · Cited by 210
Cortés-Martín, A., García-Villalba, R., González-Sarrías, A., Romo-Vaquero, M., Loria-Kohen, V., Ramírez-de-Molina, A., Tomás-Barberán, F. A., Selma, M. V., & Espín, J. C. (2018) · Food & Function · doi:10.1039/c8fo00956b · Cited by 203
Self-citationFecal microbiota transplantation to treat Parkinson's disease with constipation: A case report
Huang, H., Xu, H., Luo, Q., He, J., Li, M., Chen, H., Tang, W., Nie, Y., & Zhou, Y. (2019) · Medicine · doi:10.1097/md.0000000000016163 · Cited by 201
Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
Kuai, X.-Y., Yao, X.-H., Xu, L.-J., Zhou, Y.-Q., Zhang, L.-P., Liu, Y., Pei, S.-F., & Zhou, C.-L. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01589-0 · Cited by 179
Singh, J., Metrani, R., Shivanagoudra, S. R., Jayaprakasha, G. K., & Patil, B. S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b07306 · Cited by 178
Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies
Kujawska, M., & Jodynis-Liebert, J. (2018) · Nutrients · doi:10.3390/nu10050642 · Cited by 175
Selma, M. V., González-Sarrías, A., Salas-Salvadó, J., Andrés-Lacueva, C., Alasalvar, C., Örem, A., Tomás-Barberán, F. A., & Espín, J. C. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.03.012 · Cited by 162
Self-citationGordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut
Selma, M. V., Tomás-Barberán, F. A., Beltrán, D., García-Villalba, R., & Espín, J. C. (2014) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.055095-0 · Cited by 155
Self-citationXu, J., Yuan, C., Wang, G., Luo, J., Ma, H., Xu, L., Mu, Y., Li, Y., Seeram, N. P., Huang, X., et al. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03285 · Cited by 144
García-Villalba, R., Espín, J. C., & Tomás-Barberán, F. A. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.08.044 · Cited by 139
Self-citationRomo‐Vaquero, M., Cortés‐Martín, A., Loria‐Kohen, V., Ramírez‐de‐Molina, A., García‐Mantrana, I., Collado, M. C., Espín, J. C., & Selma, M. V. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800958 · Cited by 135
Self-citationMetta, V., Leta, V., Mrudula, K. R., Prashanth, L. K., Goyal, V., Borgohain, R., Chung-Faye, G., & Chaudhuri, K. R. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10567-w · Cited by 130
Álvarez-Luquín, D. D., Arce-Sillas, A., Leyva-Hernández, J., Sevilla-Reyes, E., Boll, M. C., Montes-Moratilla, E., Vivas-Almazán, V., Pérez-Correa, C., Rodríguez-Ortiz, U., Espinoza-Cárdenas, R., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1606-1 · Cited by 108
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H.-L., & Lin, C.-H. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 104
Cortés‐Martín, A., Iglesias‐Aguirre, C. E., Meoro, A., Selma, M. V., & Espín, J. C. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001048 · Cited by 60
Self-citationPolyphenols’ Gut Microbiota Metabolites: Bioactives or Biomarkers?
Tomás-Barberán, F. A., Selma, M. V., & Espín, J. C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00827 · Cited by 58
Self-citationBacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
van Kessel, S. P., & El Aidy, S. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191780 · Cited by 52
Vascellari, S., Melis, M., Palmas, V., Pisanu, S., Serra, A., Perra, D., Santoru, M. L., Oppo, V., Cusano, R., Uva, P., et al. (2021) · Biomolecules · doi:10.3390/biom11020144 · Cited by 48
Xian, W., Yang, S., Deng, Y., Yang, Y., Chen, C., Li, W., & Yang, R. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04849 · Cited by 48
Hasuike, Y., Endo, T., Koroyasu, M., Matsui, M., Mori, C., Yamadera, M., Fujimura, H., & Sakoda, S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109436 · Cited by 42
Cortés-Martín, A., Colmenarejo, G., Selma, M. V., & Espín, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-64833-4 · Cited by 41
Self-citationCortés‐Martín, A., Romo‐Vaquero, M., García‐Mantrana, I., Rodríguez-Varela, A., Collado, M. C., Espín, J. C., & Selma, M. V. (2019) · Nutrients · doi:10.3390/nu11092079 · Cited by 37
Self-citationMethionine utilization by bifidobacteria: possible existence of a reverse transsulfuration pathway
Wada, M., Fukiya, S., Suzuki, A., MATSUMOTO, N., MATSUO, M., & Yokota, A. (2020) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2020-031 · Cited by 17
Aquilonius, S. M., & Fuxé, K. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.02.009 · Cited by 1
Research works printed but not linked: 4
- Hill, 2021, Front. Neurosci., 15, 1
- Sun, 2018, Ageing Res. Rev., 45, 53, 10.1016/j.arr.2018.04.004 · DOI · Paper page
- Smirnova, 2005, Biochemistry, 70, 1199
- Zheng, 2017, Front. Microbiol., 8, 1
Cited by
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 159
Approach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
(Poly)phenol-related gut metabotypes and human health: an update
Hu, J., Mesnage, R., Tuohy, K. M., Heiß, C., & Rodriguez‐Mateos, A. (2024) · Food & Function · doi:10.1039/d3fo04338j · Cited by 91
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Metadata
- Authors
- Romo-Vaquero, M., Fernández-Villalba, E., Gil-Martinez, A.-L., Cuenca-Bermejo, L., Espín, J. C., Herrero, M. T., & Selma, M. V.
- Affiliations
- Laboratory of Food & Health, Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, Campus de Espinardo, Murcia 30100, Spain
- Institute of Biomedical Research of Murcia (IMIB), Campus de Ciencias de la Salud, Carretera Buenavista s/n, El Palmar, Murcia 30120, Spain
- Instituto Murciano de Investigación Biosanitaria (ES)
- Corresponding author
- Herrero, María Trinidad
- Venue
- Food & Function
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 13
- Issue
- 11
- Pages
- 6306-6316
- ISSN
- 2042-6496 (ISSN-L)
- 2042-650X
- OpenAlex
- W4282928102
- Cited by
- 54
- References
- 44
- Citations by year
- 2026: 16 · 2025: 11 · 2024: 16 · 2023: 7 · 2022: 4
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Food & Function (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc)
- Hispana (submittedVersion, cc-by-nc-nd)
- Funders
- Consejo Superior de Investigaciones Científicas (PIE201570I005)
- Fundación Séneca (FS/20880/PI/18)
- Ministerio de Ciencia e Innovación (AGL2015-64124-R and PID2019-103914RB-I00)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
- Keywords
- urolithins, Parkinson's disease, gut dysbiosis, gut microbiota, biomarkers, disease stage, intestinal inflammation, lipopolysaccharide biosynthesis, glutathione metabolism, cysteine and methionine metabolism, urinary biomarkers, non-invasive diagnosis, microbiota-targeted interventions
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Humans, Parkinson Disease, Biomarkers, Juglans, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.